As of 2026-01-05, the Relative Valuation of Cassava Sciences Inc (SAVA) is (40.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.09 USD, the upside of Cassava Sciences Inc based on Relative Valuation is -2048.0%.
The range of the Relative Valuation is (39.99) - (42.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 19.5x | 18.0x |
| Forward P/E multiples | 18.2x - 20.5x | 19.1x |
| Fair Price | (39.99) - (42.84) | (40.71) |
| Upside | -2013.4% - -2149.9% | -2048.0% |
| Date | P/E |
| 2025-12-31 | -0.90 |
| 2025-12-30 | -0.92 |
| 2025-12-29 | -0.95 |
| 2025-12-26 | -0.99 |
| 2025-12-24 | -1.02 |
| 2025-12-23 | -1.00 |
| 2025-12-22 | -1.08 |
| 2025-12-19 | -0.99 |
| 2025-12-18 | -1.30 |
| 2025-12-17 | -1.30 |
| 2025-12-16 | -1.33 |
| 2025-12-15 | -1.28 |
| 2025-12-12 | -1.33 |
| 2025-12-11 | -1.44 |
| 2025-12-10 | -1.49 |
| 2025-12-09 | -1.48 |
| 2025-12-08 | -1.46 |
| 2025-12-05 | -1.45 |
| 2025-12-04 | -1.51 |
| 2025-12-03 | -1.41 |
| 2025-12-02 | -1.32 |
| 2025-12-01 | -1.38 |
| 2025-11-28 | -1.48 |
| 2025-11-26 | -1.54 |
| 2025-11-25 | -1.39 |
| 2025-11-24 | -1.32 |
| 2025-11-21 | -1.31 |
| 2025-11-20 | -1.20 |
| 2025-11-19 | -1.25 |
| 2025-11-18 | -1.27 |
| 2025-11-17 | -1.27 |
| 2025-11-14 | -1.26 |
| 2025-11-13 | -1.34 |
| 2025-11-12 | -1.49 |
| 2025-11-11 | -1.42 |
| 2025-11-10 | -1.38 |
| 2025-11-07 | -1.35 |
| 2025-11-06 | -1.35 |
| 2025-11-05 | -1.39 |
| 2025-11-04 | -1.35 |
| 2025-11-03 | -1.45 |
| 2025-10-31 | -1.49 |
| 2025-10-30 | -1.49 |
| 2025-10-29 | -1.56 |
| 2025-10-28 | -1.63 |
| 2025-10-27 | -1.73 |
| 2025-10-24 | -1.72 |
| 2025-10-23 | -1.78 |
| 2025-10-22 | -1.69 |
| 2025-10-21 | -1.81 |